Table 1 Demographic profile of patients (n = 107).

From: Saroglitazar in patients with non-alcoholic fatty liver disease and diabetic dyslipidemia: a prospective, observational, real world study

Characteristic

 

Age (years)

50.4 ± 12.3

Male gender

84 (78.5)

Urban residence

71 (66.4)

Weight (kg)

83.5 ± 15.1

BMI (kg/m2)

28.8 ± 4.2

Normal BMI (18.5–22.9)

11 (10.3)

Over weight (23–24.9)

21 (19.6)

Pre-obese (25.0–29.9)

37 (34.6)

Obese type 1 (30–39.9)

35 (32.7)

Obese type 2 (40–49.9)

3 (2.8)

Obese type 3 (> 50)

0 (0.0)

SBP (mmHg)

143.5 ± 30.6

DBP (mmHg)

91.4 ± 15.9

Comorbidities

 

Diabetes

107 (100)

Duration of diabetes (years)

8.4 ± 5.3

Hypertension

56 (52.3)

Coronary artery disease

19 (17.8)

Hypothyroidism

11 (10.3)

  1. Data are expressed as mean ± S.D or number (percentage).
  2. BMI, Body mass index; DBP, Diastolic Blood pressure; SBP, Systolic Blood Pressure.
Back to article page